Jason Rickard is COO & VP at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 8 open-market trades across 1 company since 2020, most recently 2023-03-08.
CIK 0001808505
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRWD | 376,316 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2023-03-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IRWD | SELL | 2023-02-27 | 2023-03-01 | $11.36 | $700K | -7.8% | -7.5% | -5.5% |
| IRWD | SELL | 2022-12-14 | 2022-12-16 | $12.39 | $335K | +3.7% | -4.8% | -12.7% |
| IRWD | SELL · 10b5-1 | 2022-08-15 | 2022-08-17 | $11.77 | $12K | -7.2% | -8.7% | -2.7% |
| IRWD | SELL | 2022-08-08 | 2022-08-10 | $11.70 | $766K | -1.6% | -6.4% | -0.3% |
| IRWD | SELL | 2022-05-23 | 2022-05-25 | $11.50 | $156K | +8.9% | +1.8% | +4.2% |
| IRWD | SELL | 2022-02-28 | 2022-03-02 | $10.77 | $569K | +6.5% | +14.7% | +3.1% |
| IRWD | SELL | 2021-12-16 | 2021-12-20 | $11.28 | $305K | +2.3% | -1.8% | +8.2% |
| IRWD | SELL | 2021-11-23 | 2021-11-24 | $11.58 | $393K | +0.8% | +3.0% | -4.2% |
| IRWD | SELL · 10b5-1 | 2021-08-16 | 2021-08-18 | $13.48 | $9K | +1.6% | -5.5% | -5.9% |
| IRWD | SELL · 10b5-1 | 2021-05-24 | 2021-05-26 | $12.25 | $6K | -5.1% | +8.5% | +9.8% |
| IRWD | SELL | 2021-02-26 | 2021-03-02 | $9.11 | $180K | +11.5% | +7.2% | +13.9% |
| IRWD | SELL · 10b5-1 | 2020-11-09 | 2020-11-10 | $10.92 | $4K | +2.2% | +5.1% | -7.5% |
| IRWD | SELL · 10b5-1 | 2020-08-17 | 2020-08-19 | $10.14 | $7K | -3.0% | -3.9% | +14.8% |
| IRWD | SELL · 10b5-1 | 2020-05-11 | 2020-05-13 | $10.35 | $5K | +12.5% | -12.1% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.